Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
21154 | 431 | 22.3 | 42% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
658 | 3 | COENZYME Q10//UBIQUINONE//COENZYME Q | 11100 |
2774 | 2 | VINPOCETINE//NEFIRACETAM//PIRACETAM | 3137 |
21154 | 1 | CAS 17479 19 5//DECMER INTENS//DORSAL HAND VEIN | 431 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CAS 17479 19 5 | authKW | 573857 | 2% | 90% | 9 |
2 | DECMER INTENS | authKW | 503798 | 2% | 89% | 8 |
3 | DORSAL HAND VEIN | authKW | 302022 | 2% | 47% | 9 |
4 | CAS 14271 05 7 | authKW | 226708 | 1% | 80% | 4 |
5 | DIHYDROERGOCRISTINE CLINICAL STUDIES | authKW | 159404 | 1% | 75% | 3 |
6 | ALMIRID R | authKW | 141694 | 0% | 100% | 2 |
7 | ALPHA DIHYDROERGOCRYPTINE PHARMACOKINETICS | authKW | 141694 | 0% | 100% | 2 |
8 | DIHYDROERGOKRYPTINE | authKW | 141694 | 0% | 100% | 2 |
9 | DIHYDROERGOTOXINE | authKW | 125945 | 1% | 44% | 4 |
10 | CAS 8067 24 1 | authKW | 94461 | 0% | 67% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 4638 | 60% | 0% | 258 |
2 | Chemistry, Medicinal | 273 | 8% | 0% | 35 |
3 | Peripheral Vascular Diseases | 118 | 6% | 0% | 24 |
4 | Medicine, General & Internal | 106 | 9% | 0% | 38 |
5 | Geriatrics & Gerontology | 78 | 3% | 0% | 11 |
6 | Medicine, Research & Experimental | 74 | 6% | 0% | 26 |
7 | Physiology | 48 | 5% | 0% | 20 |
8 | Chemistry, Analytical | 26 | 5% | 0% | 21 |
9 | Cardiac & Cardiovascular System | 22 | 4% | 0% | 18 |
10 | Neurosciences | 18 | 6% | 0% | 28 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ARBEITSGRP EXPT ANGIOL | 70847 | 0% | 100% | 1 |
2 | ESTENSE HOSP | 70847 | 0% | 100% | 1 |
3 | HISTOCHEM S | 70847 | 0% | 100% | 1 |
4 | KKS D DEN COORDINAT CLIN TRIALS | 70847 | 0% | 100% | 1 |
5 | MOLEC NEUROPHARMACOL BIJENICKA C 54 POB 1016 | 70847 | 0% | 100% | 1 |
6 | RRB 560 | 70847 | 0% | 100% | 1 |
7 | UNIT 322 | 70847 | 0% | 100% | 1 |
8 | PHARMACEUT FERMENTAT IND DEV | 35422 | 0% | 50% | 1 |
9 | PHARMBIODYN | 35422 | 0% | 50% | 1 |
10 | INTEGRAT HUMAN CARDIOVASC PHYSIOL CARDIAC SURG | 23614 | 0% | 33% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | IUGOSLAVICA PHYSIOLOGICA ET PHARMACOLOGICA ACTA | 32703 | 3% | 3% | 15 |
2 | ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH | 7783 | 5% | 1% | 22 |
3 | EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS | 5563 | 3% | 1% | 11 |
4 | JOURNAL DE PHARMACOLOGIE | 5277 | 1% | 1% | 5 |
5 | INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS | 4075 | 3% | 0% | 15 |
6 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 3598 | 4% | 0% | 19 |
7 | HERZ KREISLAUF | 3547 | 2% | 1% | 7 |
8 | ACTA PHARMACEUTICA JUGOSLAVICA | 2743 | 1% | 1% | 4 |
9 | INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH | 2653 | 1% | 1% | 6 |
10 | CLINICAL PHARMACOLOGY & THERAPEUTICS | 2366 | 3% | 0% | 14 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CAS 17479 19 5 | 573857 | 2% | 90% | 9 | Search CAS+17479+19+5 | Search CAS+17479+19+5 |
2 | DECMER INTENS | 503798 | 2% | 89% | 8 | Search DECMER+INTENS | Search DECMER+INTENS |
3 | DORSAL HAND VEIN | 302022 | 2% | 47% | 9 | Search DORSAL+HAND+VEIN | Search DORSAL+HAND+VEIN |
4 | CAS 14271 05 7 | 226708 | 1% | 80% | 4 | Search CAS+14271+05+7 | Search CAS+14271+05+7 |
5 | DIHYDROERGOCRISTINE CLINICAL STUDIES | 159404 | 1% | 75% | 3 | Search DIHYDROERGOCRISTINE+CLINICAL+STUDIES | Search DIHYDROERGOCRISTINE+CLINICAL+STUDIES |
6 | ALMIRID R | 141694 | 0% | 100% | 2 | Search ALMIRID+R | Search ALMIRID+R |
7 | ALPHA DIHYDROERGOCRYPTINE PHARMACOKINETICS | 141694 | 0% | 100% | 2 | Search ALPHA+DIHYDROERGOCRYPTINE+PHARMACOKINETICS | Search ALPHA+DIHYDROERGOCRYPTINE+PHARMACOKINETICS |
8 | DIHYDROERGOKRYPTINE | 141694 | 0% | 100% | 2 | Search DIHYDROERGOKRYPTINE | Search DIHYDROERGOKRYPTINE |
9 | DIHYDROERGOTOXINE | 125945 | 1% | 44% | 4 | Search DIHYDROERGOTOXINE | Search DIHYDROERGOTOXINE |
10 | CAS 8067 24 1 | 94461 | 0% | 67% | 2 | Search CAS+8067+24+1 | Search CAS+8067+24+1 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | BICALHO, B , GIOLO, JM , LILLA, S , DE NUCCI, G , (2008) IDENTIFICATION AND HUMAN PHARMACOKINETICS OF DIHYDROERGOTOXINE METABOLITES IN MAN: PRELIMINARY RESULTS.BIOPHARMACEUTICS & DRUG DISPOSITION. VOL. 29. ISSUE 1. P. 17-28 | 15 | 75% | 2 |
2 | GUERZONI, A , SANTAMBROGIO, S , (1995) EFFICACY OF DIHYDROERGOCRISTINE 20MG ONCE-DAILY IN PATIENTS WITH ORGANIC BRAIN PSYCHOSYNDROME - A 3-MONTH RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY.CLINICAL DRUG INVESTIGATION. VOL. 10. ISSUE 1. P. 1-7 | 16 | 84% | 1 |
3 | FRIEDRICH, G , APPEL, K , ROSE, T , WANGEMANN, M , ALTHAUS, M , RISSLER, K , (2004) DETERMINATION OF DIHYDROERGOCRYPTINE IN HUMAN PLASMA AND URINE SAMPLES USING ON-LINE SAMPLE EXTRACTION-COLUMN-SWITCHING REVERSED-PHASE LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY.JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES. VOL. 808. ISSUE 2. P. 131-139 | 14 | 61% | 6 |
4 | PAGLIANO, FM , GALBIATI, GC , (1995) COMPARISON OF THE EFFICACY AND SAFETY OF DAILY DOSAGES OF 6 MG AND 20 MG DIHYDROERGOCRISTINE IN THE TREATMENT OF CHRONIC CEREBROVASCULAR-DISEASE.JOURNAL OF INTERNATIONAL MEDICAL RESEARCH. VOL. 23. ISSUE 4. P. 219-227 | 11 | 92% | 1 |
5 | EL-DIN, MMKS , NASSAR, MWI , ATTIA, KAM , EL DEMELLAWY, MA , KADDAH, MMY , (2016) VALIDATED LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY METHOD FOR SIMULTANEOUS DETERMINATION OF CLOPAMIDE, RESERPINE AND DIHYDROERGOTOXINE: APPLICATION TO PHARMACOKINETICS IN HUMAN PLASMA.JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS. VOL. 125. ISSUE . P. 236 -244 | 10 | 53% | 0 |
6 | FRANCIOSI, A , ZAVATTINI, G , (1994) DIHYDROERGOCRISTINE IN THE TREATMENT OF ELDERLY PATIENTS WITH COGNITIVE DETERIORATION - A DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RESPONSE STUDY.CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL. VOL. 55. ISSUE 11. P. 1391-1401 | 12 | 80% | 4 |
7 | WYSS, PA , ROSENTHALER, J , NUESCH, E , AELLIG, WH , (1991) PHARMACOKINETIC INVESTIGATION OF ORAL AND IV-DIHYDROERGOTAMINE IN HEALTHY-SUBJECTS.EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. VOL. 41. ISSUE 6. P. 597-602 | 13 | 81% | 16 |
8 | AELLIG, WH , (1994) CLINICAL-PHARMACOLOGY, PHYSIOLOGY AND PATHOPHYSIOLOGY OF SUPERFICIAL VEINS .2..BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. VOL. 38. ISSUE 4. P. 289 -305 | 36 | 24% | 38 |
9 | GROGNET, JM , RIVIERE, R , ISTIN, M , ZANOTTI, A , COPPI, G , (1992) PHARMACOKINETICS OF DIHYDROERGOCRISTINE FOLLOWING INTRAVENOUS AND ORAL-ADMINISTRATION IN RATS.ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH. VOL. 42-2. ISSUE 11A. P. 1394-1396 | 10 | 100% | 0 |
10 | MULLERSCHWEINITZER, E , ROSENTHALER, J , (1987) DIHYDROERGOTAMINE - PHARMACOKINETICS, PHARMACODYNAMICS, AND MECHANISM OF VENOCONSTRICTOR ACTION IN BEAGLE DOGS.JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. VOL. 9. ISSUE 6. P. 686-693 | 19 | 63% | 17 |
Classes with closest relation at Level 1 |